Pieris Pharmaceuticals In... (PIRS)
NASDAQ: PIRS
· Real-Time Price · USD
13.60
-2.51 (-15.58%)
At close: Dec 13, 2024, 9:00 PM
Pieris Pharmaceuticals Revenue
Pieris Pharmaceuticals reported an annual revenue of $42.81M, reflecting a 65.28% growth. For the quarter ending September 30, 2024, Pieris Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
$42.81M
Revenue Growth
65.28%
Price / Sales Ratio
0.38
Revenue / Employee
$930.65K
Employees
46
Market Cap
17.96M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|